Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The $69 billion merger between Aetna, one of the nation’s largest health insurers, and CVS, a major retail pharmacy chain and pharmacy benefit manager, has been touted as a “transformative moment” moment for the healthcare industry. Now that the deal has been completed, consumers are split on whether they'll move their care to the retailer.
Despite AI’s potential in healthcare, major ethical concerns—like consent, transparency and responsibility—still surround the technology and its use in medicine. To address those concerns, Georgia researchers are encouraging physicians and healthcare companies to provide detailed information on AI systems to mitigate concerns patients may have with the technology.
For better healthcare, the U.S. needs more primary care physicians. In a study of U.S. population data, greater PCP supply was associated with improved mortality rates, but per capita PCP supply decreased between 2005 and 2015, according to a new study published in JAMA Internal Medicine.
Nurses with poor physical and mental health—particularly depression—are more likely to make medical errors in the workplace, according to new research published in the Journal for Occupational and Environmental Medicine.
The Vanderbilt University Medical Center (VUMC) is looking to transform electronic health records (EHRs) by leveraging voice and AI technology to allow EHRs to naturally interact with physicians to find relevant information and hopefully enhance patient care.
Researchers at Georgia Tech have developed a new AI-based app, MyPath, that adapts to each stage of a patient’s cancer journey with personalized resources and recommendations on everything from side effects to insurance and more.
Researchers from the Imperial College London and the University of Melbourne created a new AI algorithm that is four times more accurate in predicting survival rates among ovarian cancer patients. The tool was also able to determine the most effective treatment for patients who exhibit ovarian cancer. Research findings were published in Nature Communications.
